HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Expanded arsenal in atrial fibrillation: bye-bye marcumar?].

Authors
JournalMMW Fortschritte der Medizin (MMW Fortschr Med) Vol. 154 Issue 1 Pg. 20 (Jan 19 2012) ISSN: 1438-3276 [Print] Germany
Vernacular TitleErweitertes Arsenal bei Vorhofflimmern: Bye-bye Marcumar?
PMID22641998 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Antithrombins
  • Benzimidazoles
  • Factor Xa Inhibitors
  • Morpholines
  • Thiophenes
  • beta-Alanine
  • Rivaroxaban
  • Dabigatran
  • Phenprocoumon
Topics
  • Anticoagulants (adverse effects, therapeutic use)
  • Antithrombins (adverse effects, therapeutic use)
  • Atrial Fibrillation (therapy)
  • Benzimidazoles (adverse effects, therapeutic use)
  • Dabigatran
  • Drug Approval
  • Drug Interactions
  • Drug Substitution
  • Factor Xa Inhibitors
  • Germany
  • Humans
  • Morpholines (adverse effects, therapeutic use)
  • Phenprocoumon (adverse effects, therapeutic use)
  • Rivaroxaban
  • Thiophenes (adverse effects, therapeutic use)
  • Thromboembolism (prevention & control)
  • beta-Alanine (adverse effects, analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: